BioNTech SE (BNTX) Income from Non-Controlling Interests (2018 - 2025)
BioNTech SE (BNTX) posted Income from Non-Controlling Interests of $17710.2 for Q4 2019, down 87.26% sequentially from $138973.0 in Q4 2018, and down 87.26% YoY from $138973.0 in Q4 2018.
Powered by 
Analysis
BioNTech SE (BNTX) Income from Non-Controlling Interests (2018 - 2025) Analysis & Trends
BioNTech SE has reported Income from Non-Controlling Interests for 2 years, with the latest figure at $17710.2 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 63.60 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | BioNTech SE | 25.12 Bn | 11.47 Bn | 10.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -66.27 Mn |
| Mar 31, 2024 | 24.23 Mn |
| Dec 31, 2019 | 17,710.20 |
| Mar 31, 2019 | -131,848.95 |
| Dec 31, 2018 | -138,108.97 |
| Sep 30, 2018 | -54,667.07 |